Buys | $2,768,372 | 5 | 71 |
Sells | $127,288 | 2 | 29 |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 5 | $2.77M | 0 | $0 | $2.77M |
Greenberg Bruce | See Remarks | 0 | $0 | 1 | $51,313 | $-51,313 |
Machatha Stephen | Chief Development Officer | 0 | $0 | 1 | $75,975 | $-75,975 |
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in …
Over the last 12 months, insiders at Aldeyra Therapeutics, Inc. have bought $2.77M and sold $127,288 worth of Aldeyra Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Aldeyra Therapeutics, Inc. have bought $12.32M and sold $2.65M worth of stock each year.
Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $2.77M.
The last purchase of 37,712 shares for transaction amount of $178,755 was made by PERCEPTIVE ADVISORS LLC (10 percent owner) on 2024‑04‑05.
2024-08-12 | Sale | Machatha Stephen | Chief Development Officer | 16,041 0.0272% | $4.74 | $75,975 | +12.53% | |
2024-08-12 | Sale | Greenberg Bruce | See Remarks | 10,834 0.0184% | $4.74 | $51,313 | +12.53% | |
2024-04-05 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 37,712 0.0643% | $4.74 | $178,755 | +4.98% | ||
2024-04-04 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 140,281 0.2374% | $4.67 | $655,112 | +5.77% | ||
2024-04-03 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 309,847 0.5185% | $4.09 | $1.27M | +19.16% | ||
2024-04-02 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 186,051 0.3061% | $3.44 | $640,015 | +39.15% | ||
2024-04-01 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 8,374 0.0141% | $3.25 | $27,216 | +51.07% | ||
2024-03-12 | Sale | Brady Todd C | President and CEO | 85,324 0.147% | $3.05 | $260,238 | +62.13% | |
2024-03-12 | Sale | Machatha Stephen | Chief Development Officer | 11,537 0.0206% | $3.16 | $36,503 | +62.13% | |
2024-03-11 | Sale | Brady Todd C | President and CEO | 97,914 0.1675% | $3.27 | $320,521 | +49.85% | |
2024-03-11 | Sale | Machatha Stephen | Chief Development Officer | 18,231 0.0324% | $3.41 | $62,102 | +49.85% | |
2024-03-11 | Sale | Greenberg Bruce | See Remarks | 13,201 0.0235% | $3.41 | $44,968 | +49.85% | |
2023-10-18 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 306,499 0.5276% | $1.74 | $533,308 | +112.14% | |
2023-10-16 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 2.45M 3.6657% | $1.60 | $3.92M | +98.63% | |
2023-04-12 | Miller-Rich Nancy | director | 509 0.0009% | $10.13 | $5,156 | -45.04% | ||
2022-08-09 | EDELMAN JOSEPH | 15,000 0.027% | $7.85 | $117,750 | -4.83% | |||
2022-08-08 | EDELMAN JOSEPH | 97,000 0.1669% | $7.24 | $702,280 | -1.53% | |||
2022-08-05 | EDELMAN JOSEPH | 141,000 0.2422% | $6.95 | $979,950 | +2.46% | |||
2022-08-04 | EDELMAN JOSEPH | 95,100 0.1609% | $6.17 | $586,767 | +13.62% | |||
2022-08-03 | EDELMAN JOSEPH | 100,000 0.1722% | $5.84 | $584,000 | +21.90% |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 9275851 15.5352% | $63.17M | 18 | 2 | +4.56% |
EDELMAN JOSEPH | 11350085 19.0091% | $77.29M | 9 | 0 | +19.39% | |
Brady Todd C | President and CEO | 1471298 2.4641% | $10.02M | 11 | 2 | +8.57% |
DOUGLAS RICHARD | director | 125000 0.2093% | $851,250.00 | 7 | 0 | +43% |
Reed Joshua | Chief Financial Officer | 35774 0.0599% | $243,620.94 | 1 | 0 | +5.74% |
Aldeyra Therapeutics, Inc. (ALDX) | $84,871,118 | 57 | 17.71% | $406.62M |
$24,384,691 | 42 | -30.27% | $400.47M | |
$26,923,982 | 20 | -17.22% | $415.61M | |
$73,222,926 | 18 | 60.19% | $406.77M | |
$100,566,697 | 18 | -5.10% | $466.15M |
Increased Positions | 65 | +57.52% | 4M | +11.49% |
Decreased Positions | 41 | -36.28% | 3M | -8.53% |
New Positions | 24 | New | 2M | New |
Sold Out Positions | 18 | Sold Out | 1M | Sold Out |
Total Postitions | 137 | +21.24% | 38M | +2.96% |
Perceptive Advisors Llc | $47,400.00 | 15.46% | 9.28M | 0 | 0% | 2024-12-31 |
Knoll Capital Management, Llc | $27,980.00 | 9.13% | 5.48M | 0 | 0% | 2024-12-31 |
Blackrock, Inc. | $19,368.00 | 6.32% | 3.79M | +55,782 | +1.49% | 2024-12-31 |
Vanguard Group Inc | $19,197.00 | 6.26% | 3.76M | -3,831 | -0.1% | 2024-12-31 |
Kennedy Capital Management Llc | $7,504.00 | 2.45% | 1.47M | -412,559 | -21.93% | 2024-12-31 |
Ardsley Advisory Partners Lp | $5,877.00 | 1.92% | 1.15M | +650,000 | +130% | 2024-12-31 |
Geode Capital Management, Llc | $5,721.00 | 1.87% | 1.12M | +4,927 | +0.44% | 2024-12-31 |
State Street Corp | $5,281.00 | 1.72% | 1.03M | +59,465 | +6.11% | 2024-12-31 |
Dimensional Fund Advisors Lp | $3,760.00 | 1.23% | 735,763 | +131,722 | +21.81% | 2024-12-31 |
Raymond James Financial Inc | $3,716.00 | 1.21% | 727,118 | +727,118 | New | 2024-12-31 |